Literature DB >> 11035065

Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation.

G Eberl1, P Brawand, H R MacDonald.   

Abstract

Ag-experienced or memory T cells have increased reactivity to recall Ag, and can be distinguished from naive T cells by altered expression of surface markers such as CD44. Memory T cells have a high turnover rate, and CD8(+) memory T cells proliferate upon viral infection, in the presence of IFN-alphabeta and/or IL-15. In this study, we extend these findings by showing that activated NKT cells and superantigen-activated T cells induce extensive bystander proliferation of both CD8(+) and CD4(+) memory T cells. Moreover, proliferation of memory T cells can be induced by an IFN-alphabeta-independent, but IFN-gamma- or IL-12-dependent pathway. In these conditions of bystander activation, proliferating memory (CD44(high)) T cells do not derive from activation of naive (CD44(low)) T cells, but rather from bona fide memory CD44(high) T cells. Together, these data demonstrate that distinct pathways can induce bystander proliferation of memory T cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035065     DOI: 10.4049/jimmunol.165.8.4305

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

Review 1.  Qualitative differences between naïve and memory T cells.

Authors:  Marion Berard; David F Tough
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

2.  NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge.

Authors:  Adam P Uldrich; Nadine Y Crowe; Konstantinos Kyparissoudis; Daniel G Pellicci; Yifan Zhan; Andrew M Lew; Philippe Bouillet; Andreas Strasser; Mark J Smyth; Dale I Godfrey
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

3.  Neutrophils are required for 3-methylcholanthrene-initiated, butylated hydroxytoluene-promoted lung carcinogenesis.

Authors:  Haris G Vikis; Andrew E Gelman; Andrew Franklin; Lauren Stein; Amy Rymaszewski; Jihong Zhu; Pengyuan Liu; Jay W Tichelaar; Alexander S Krupnick; Ming You
Journal:  Mol Carcinog       Date:  2011-10-17       Impact factor: 4.784

4.  TCR Valpha14 natural killer T cells function as effector T cells in mice with collagen-induced arthritis.

Authors:  Y Ohnishi; A Tsutsumi; D Goto; S Itoh; I Matsumoto; M Taniguchi; T Sumida
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

5.  Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.

Authors:  Yoshinori Ikarashi; Akira Iizuka; Yumie Koshidaka; Yuji Heike; Yoichi Takaue; Mitsuzi Yoshida; Mitchell Kronenberg; Hiro Wakasugi
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

6.  Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine.

Authors:  A W Zuercher; M A Imboden; S Jampen; D Bosse; M Ulrich; H Chtioui; B H Lauterburg; A B Lang
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

7.  During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment.

Authors:  Malcolm S Duthie; Stuart J Kahn
Journal:  Immunology       Date:  2006-07-26       Impact factor: 7.397

8.  Human CD4(+) effector T lymphocytes generated upon TCR engagement with self-peptides respond defectively to IL-7 in their transition to memory cells.

Authors:  Gabriela González-Pérez; Norma C Segovia; Amaranta Rivas-Carvalho; Diana P Reyes; Honorio Torres-Aguilar; Sergio R Aguilar-Ruiz; Claudine Irles; Gloria Soldevila; Carmen Sánchez-Torres
Journal:  Cell Mol Immunol       Date:  2013-03-04       Impact factor: 11.530

9.  Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy.

Authors:  Weihua Song; Hans J J van der Vliet; Yu-Tzu Tai; Rao Prabhala; Ruojie Wang; Klaus Podar; Laurence Catley; Masood A Shammas; Kenneth C Anderson; Steven P Balk; Mark A Exley; Nikhil C Munshi
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

10.  Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania.

Authors:  Blaise Dondji; Eszter Deak; Karen Goldsmith-Pestana; Eva Perez-Jimenez; Mariano Esteban; Sachiko Miyake; Takashi Yamamura; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.